As of December 2024, Excelsior Biopharma has a market cap of $43.11M. This makes Excelsior Biopharma the world's 24065th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $40.31M | -2.77% |
2023 | $41.46M | 3.78% |
2022 | $39.95M | -4.96% |
2021 | $42.03M | -1.35% |
2020 | $42.61M | -16.95% |
2019 | $51.30M | -12.18% |
2018 | $58.42M | -44.99% |
2017 | $106.20M | 17.30% |
2016 | $90.53M | -53.68% |
2015 | $195.44M | 119.35% |
2014 | $89.10M | - |